Phase II study of gefitinib in patients with advanced salivary gland cancers

详细信息    查看全文

• 作者：John A. Jakob ; Merrill S. Kies ; Bonnie S. Glisson ; Michael E. Kupferman ; Diane D. Liu ; J. Jack Lee ; Adel K. El-Naggar ; Ana M. Gonzalez-Angulo and George R. Blumenschein Jr
• 关键词：salivary gland cancer ; adenoid cystic carcinoma ; non-adenoid cystic carcinoma ; gefitinib ; response to therapy
• 刊名：Head & Neck
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：37
• 期：5
• 页码：644-649
• 全文大小：196K
• ISSN：1097-0347

文摘

The purpose of this study was to determine the antitumor activity of the epidermal growth factor receptor (EGFR) inhibitor gefitinib in patients with recurrent/metastatic salivary gland cancer.